Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this ...

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 194 % ...

Regeneron is building a $2 billion production facility in Saratoga Springs that will allow the Tarrytown drugmaker to double ...

Regeneron Pharmaceuticals (REGN) shares have been in focus recently, attracting investor interest thanks to their steady ...

Regeneron stock increased by 19% over the past month, driven by strong third-quarter earnings. But is Gilead the better pick?

New details have emerged about what Regeneron is planning for the Saratoga Springs site it acquired last year.

In May, Jonathan Polkes ’84 secured a blockbuster $460.8 million jury verdict as lead counsel for Regeneron Pharmaceuticals ...

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Pharmaceuticals announced new and updated data from its hematology portfolio and pipeline will be shared across 14 abstracts at ...